benzbromarone has been researched along with Metabolic Diseases in 2 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uric acid was studied before and after administration of pyrazinamide and benzbromarone." | 1.26 | Isolated defect in postsecretory reabsorption of uric acid. ( Levinson, DJ; Sorensen, LB, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, WW | 1 |
| Gallo, L | 1 |
| Jadhav, A | 1 |
| Hawkins, R | 1 |
| Parker, CG | 1 |
| Sorensen, LB | 1 |
| Levinson, DJ | 1 |
1 review available for benzbromarone and Metabolic Diseases
| Article | Year |
|---|---|
The Druggability of Solute Carriers.
Topics: Animals; Biological Transport; Cell Membrane; Drug Discovery; Humans; Metabolic Diseases; Nervous Sy | 2020 |
1 other study available for benzbromarone and Metabolic Diseases
| Article | Year |
|---|---|
Isolated defect in postsecretory reabsorption of uric acid.
Topics: Absorption; Adult; Benzbromarone; Female; Humans; Metabolic Diseases; Pyrazinamide; Uric Acid | 1980 |